. Author manuscript; available in PMC: 2023 Jun 8.

Published in final edited form as: JACC Heart Fail. 2023 Feb 1;11(4):440–450. doi: 10.1016/j.jchf.2022.12.005

Table 3.

Distribution of Abnormal Echo Parameters by Stage B_{echo only} and Stage B_{echo+biomarker}

	Stage B_{echo only} (n = 852)	Stage B_{echo+biomarker} (n = 2,351)
LVEF <50%	0.7	4.5
Longitudinal strain <16%	33.4	30.4
Regional wall motion abnormality	0.2	1.7
LV mass index >116 g/m² in men and >95 g/m² in women	14.1	19.4
LV end diastolic volume index ≥75 mL/m² in men and ≥62 mL/m² in women	14.8	19.5
Left atrial volume index ≥29 mL/m²	36.3	53.6
Average E/e′ ≥15	25.9	35.0
Peak aortic valve velocity >300 cm/s	0.5	1.27
Mitral regurgitation jet area >4 cm²	1.1	3.8
Moderate or greater aortic insufficiency	0.5	0.8
Moderate or greater mitral stenosis	0	0
Tricuspid regurgitation velocity >280 cm/s	5.3	8.8

Values are n (%).

LV = left ventricular; LVEF = left ventricular ejection fraction.